- Home
- FSM vs RCUS Comparison
FSM vs RCUS Comparison
Compare FSM & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSM | RCUS |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.2B |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FSM | RCUS |
|---|---|---|
| Price | $11.17 | $25.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $13.61 | ★ $39.91 |
| AVG Volume (30 Days) | ★ 3.3M | 1.5M |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $247,000,000.00 |
| Revenue This Year | $37.87 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.10 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.69 | $13.21 |
| 52 Week High | $13.85 | $31.74 |
Technical Indicators
Market Signals| Indicator | FSM | RCUS |
|---|---|---|
| Relative Strength Index (RSI) | 43.92 | 45.70 |
| Support Level | $9.85 | $25.94 |
| Resistance Level | $11.29 | $26.43 |
| Average True Range (ATR) | 0.34 | 1.07 |
| MACD | -0.16 | 0.10 |
| Stochastic Oscillator | 15.02 | 58.61 |
Price Performance
Historical ComparisonAbout FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'voire, Mexico, and Peru. The company's segment consists of Mansfield, Sango, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d' Ivoire location.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.